We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App





Mindray Showcases Advanced Imaging and Laboratory Diagnostic Solutions at ECR 2021

By MedImaging International staff writers
Posted on 06 Mar 2021
Print article
Illustration
Illustration
Mindray (Shenzhen, China) exhibited its comprehensive portfolio of advanced imaging and laboratory solutions which guarantee more precise diagnosis and treatment for better patient care at the European Congress of Radiology (ECR) virtual event, March 3-10, 2021 held in Vienna, Austria.

With its deep insights into unmet clinical needs, Mindray offered a unique virtual tour at ECR 2021 with multiple intelligent applications to help address clinical challenges throughout the whole care continuum. During diagnostic procedure, quick detection and evaluation contribute greatly to improving the clinician’s confidence in disease diagnosis and early intervention. Mindray demonstrated how the application of its exclusive Ultra-wide Beam Tracking technology and Sound Touch Elastography can enable clinicians to evaluate tissue stiffness easily with comprehensive quantitative elastic analysis, thus enhancing their diagnostic confidence.

Presently, fusion imaging is widely acknowledged in ultrasound clinical practice as it combines the advantages of CT/MRI and real time ultrasound to improve the accuracy of pathology diagnosis as well as ultrasound guided intervention. Mindray amazed visitors at its ECR 2021 virtual booth with the company’s 3D US-US fusion imaging which can be applied without CT/MRI and guarantee precise and simple fusion imaging during interventional procedure.

As a non-invasive, rapid, safe and accurate examination method, ultrasound plays a significant role in monitoring patient status under different clinical environments. With dedicated solutions yet agile mobility, Mindray’s portable ultrasound can adapt to multiple environment easily with no compromise in imaging performance, helping clinicians to address diagnostic challenges and make rapid decision in the current fast-paced, overburdened and demanding hospital environments. Mindray demonstrated its MX7 and ME dedicated portable ultrasound systems, alongside its UltraSync Remote Diagnosis tele-ultrasound solution.

Mindray also provided a series of insightful educational sessions every day at its virtual booth, where a line-up of leading radiology experts came together to share their expertise and latest findings in the field of vascular imaging, CEUS, elastography, fusion imaging and so on. Advanced technologies such as CEUS and enhanced quantification measurement are strong supportive features in providing accurate diagnostic evidence for doctors. In collaboration with experts from Italy and China, Mindray presented webinars on updates in CEUS. Mindray’s virtual booth at ECR 2021 also served as a well-established platform for viewers to communicate their up-to-date ideas and technologies to key opinion leaders with just a click.

Related Links:
Mindray

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Enterprise Imaging & Reporting Solution
Syngo Carbon
New
Ceiling-Mounted Digital Radiography System
Radiography 5000 C
New
X-Ray Detector
FDR-D-EVO III

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.